Chemotactic Peptide-induced Changes of Intermediate Filament Organization in Neutrophils during Granule Secretion: Role of Cyclic Guanosine Monophosphate

von Pryzwansky, Katherine B., Merricks, Elizabeth P.
Veröffentlicht 1998

ARFI Imaging for Noninvasive Material Characterization of Atherosclerosis Part II: Toward In Vivo Characterization

von Behler, Russell H., Nichols, Timothy C., Zhu, Hongtu, Merricks, Elizabeth P., Gallippi, Caterina M.
Veröffentlicht 2008

Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test – Demonstrated in vitro and ex vivo

von Madsen, Daniel Elenius, Nichols, Timothy C., Merricks, Elizabeth P., Waters, Emily K., Wiinberg, Bo
Veröffentlicht in PLoS One (2017)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa

von Nichols, Timothy C., Levy, Howard, Merricks, Elizabeth P., Raymer, Robin A., Lee, Martin L.
Veröffentlicht in PLoS One (2020)

Influence of Diabetes on the Foreign Body Response to Nitric Oxide-Releasing Implants

von Soto, Robert J., Merricks, Elizabeth P., Bellinger, Dwight A., Nichols, Timothy C., Schoenfisch, Mark H.
Veröffentlicht in Biomaterials (2017)

Phase II Prospective Open-Label Trial of Recombinant Interleukin-11 in DDAVP-Unresponsive Von Willebrand Disease and Mild or Moderate Hemophilia A

von Ragni, Margaret V., Novelli, Enrico M., Murshed, Anila, Merricks, Elizabeth P., Kloos, Mark T., Nichols, Timothy C.
Veröffentlicht 2012

Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia()

von Ragni, Margaret V., Jankowitz, Rachel C., Jaworski, Kristen, Merricks, Elizabeth P., Kloos, Mark T., Nichols, Timothy C.
Veröffentlicht 2011

Animal Models of Hemophilia

von Sabatino, Denise E., Nichols, Timothy C., Merricks, Elizabeth, Bellinger, Dwight A., Herzog, Roland W., Monahan, Paul E.
Veröffentlicht 2012

Soy phosphatidylinositol containing lipid nanoparticle prolongs the plasma survival and hemostatic efficacy of B-domain deleted recombinant canine Factor VIII in Hemophilia A dogs

von Shetty, Krithika A., Merricks, Elizabeth P., Raymer, Robin, Rigsbee, Natalie, Nichols, Timothy C, Balu-Iyer, Sathy V.
Veröffentlicht in J Pharm Sci (2016)

Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells

von Haberichter, Sandra L., Merricks, Elizabeth P., Fahs, Scot A., Christopherson, Pamela A., Nichols, Timothy C., Montgomery, Robert R.
Veröffentlicht 2004

Portal Vein Delivery of Viral Vectors for Gene Therapy for Hemophilia

von Sherman, Alexandra, Schlachterman, Alexander, Cooper, Mario, Merricks, Elizabeth P., Raymer, Robin A., Bellinger, Dwight A., Herzog, Roland W., Nichols, Timothy C.
Veröffentlicht in Methods Mol Biol (2014)

Experimental Validation of ARFI Surveillance of Subcutaneous Hemorrhage (ASSH) Using Calibrated Infusions in a Tissue-Mimicking Model and Dogs

von Geist, Rebecca E., DuBois, Chase H., Nichols, Timothy C., Caughey, Melissa C., Merricks, Elizabeth P., Raymer, Robin, Gallippi, Caterina M.
Veröffentlicht in Ultrason Imaging (2015)

A Monoclonal Antibody Against α(V)β(3) Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs

von Maile, Laura A., Busby, Walker H., Nichols, Timothy C., Bellinger, Dwight A., Merricks, Elizabeth P., Rowland, Michael, Veluvolu, Umadevi, Clemmons, David R.
Veröffentlicht 2010

Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII

von Lozier, Jay N, Kloos, Mark T, Merricks, Elizabeth P, Lemoine, Nathaly, Whitford, Margaret H, Raymer, Robin A, Bellinger, Dwight A, Nichols, Timothy C
Veröffentlicht in Comp Med (2016)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models

von Markusic, David M., Nichols, Timothy C., Merricks, Elizabeth P., Palaschak, Brett, Zolotukhin, Irene, Marsic, Damien, Zolotukhin, Sergei, Srivastava, Arun, Herzog, Roland W.
Veröffentlicht in J Transl Med (2017)

Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model

von French, Robert A., Samelson-Jones, Benjamin J., Niemeyer, Glenn P., Lothrop, Clinton D., Merricks, Elizabeth P., Nichols, Timothy C., Arruda, Valder R.
Veröffentlicht in Blood Adv (2018)

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

von Samelson-Jones, Benjamin J., Finn, Jonathan D., Raffini, Leslie J., Merricks, Elizabeth P., Camire, Rodney M., Nichols, Timothy C., Arruda, Valder R.
Veröffentlicht in Blood Adv (2021)

Hyperactive Sleeping Beauty Transposase Enables Persistent Phenotypic Correction in Mice and a Canine Model for Hemophilia B

von Hausl, Martin A, Zhang, Wenli, Müther, Nadine, Rauschhuber, Christina, Franck, Helen G, Merricks, Elizabeth P, Nichols, Timothy C, Kay, Mark A, Ehrhardt, Anja
Veröffentlicht 2010

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies

von Nichols, Timothy C., Bellinger, Dwight A., Merricks, Elizabeth P., Raymer, Robin A., Kloos, Mark T., DeFriess, Natalie, Ragni, Margaret V., Griggs, Thomas R.
Veröffentlicht 2010

The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy

von Finn, Jonathan D., Nichols, Timothy C., Svoronos, Nikolaos, Merricks, Elizabeth P., Bellenger, Dwight A., Zhou, Shangshen, Simioni, Paolo, High, Katherine A., Arruda, Valder R.
Veröffentlicht 2012